Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

With Robert F. Kennedy Jr. set to be sworn in as HHS secretary later Thursday, one of the first tasks in his new position ...

Investors might want to bet on BioNTech SE Sponsored ADR (BNTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Pliant Therapeutics (PLRX) stock jumped 21% Thursday after the company issued an update for a Phase 2b clinical study of ...

In a report released today, Anthony Vendetti from Maxim Group reiterated a Buy rating on Clinigence Holdings (NUTX – Research Report), with a ...

Leerink Partners analyst shifted the rating for Genmab A/S (NASDAQ:GMAB) stock from Market Perform to Outperform, maintaining a price target (PT) of $27.00. The upgrade reflects a positive long-term ...

Investing.com -- Shares of Genmab (NASDAQ: GMAB) climbed 7% following the announcement of its fourth-quarter earnings, which revealed a net profit significantly surpassing consensus estimates. The ...

Nutanix (NTNX) closed the latest trading day at $70.28, indicating a -1.83% change from the previous session's end. The stock trailed the S&P 500, which registered a daily loss of 0.27%. At the same ...

Robert F. Kennedy Jr., President Trump's choice to head HHS, is a step closer to being confirmed after the Senate voted to ...

Nutanix improves financials with robust strategies against VMware, offering cost efficiencies. Strong margins ahead, but high ...

Discover how BNDX, a USD-hedged European bond ETF, offers a 3.06% yield amid diverging monetary policies and economic trends ...

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Broadstone Net Lease (BNL – Research Report), Brixmor ...